Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Efficacy,Safety and Quality of Life After TOOKAD® Soluble Vascular Targeted Photodynamic Therapy (VTP) for Minimally Invasive Treatment of Localized Prostate Cancer

NCT01875393 is registered in ClinicalTrials.gov with Steba Biotech S.A. as lead sponsor.

NCT NCT01875393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01875393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Efficacy,Safety and Quality of Life After TOOKAD® Soluble Vascular Targeted Photodynamic Therapy (VTP) for Minimally Invasive Treatment of Localized Prostate Cancer
Lead sponsor
Steba Biotech S.A.
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2013
Completion date
March 31, 2015
Enrollment
81 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer